Select Medical Holdings stock (US81642T1007): valuation in focus as merger scrutiny intensifies

Select Medical Holdings shares trade near the agreed USD 16.50 cash offer while law firms probe the announced take-private deal, putting the New York-listed health care operator's valuation metrics into the spotlight for U.S. and European investors.

Select Medical Holdings, whose shares trade on the New York Stock Exchange under the ticker SEM, remains in the spotlight after the company agreed to be acquired in an all-cash transaction valued at USD 16.50 per share, drawing additional attention from U.S. law firms reviewing the deal terms on behalf of shareholders, according to a Business Wire notice dated 05/28/2026 that references an investigation by BFA Law into the announced transaction (Business Wire as of 05/28/2026).

The stock most recently closed around USD 16.52 on the NYSE on 05/27/2026, placing it effectively in line with the agreed USD 16.50 per-share consideration and suggesting that market participants in the United States are pricing in a high likelihood of completion of the deal, based on data from MarketBeat as of 05/27/2026, even as legal reviews focus on whether the terms appropriately reflect the company’s financial profile.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: SEM
• Sector/industry: Health care services - post-acute and outpatient rehabilitation
• Headquarters/country: Mechanicsburg, United States
• Core markets: United States inpatient rehabilitation facilities, long-term acute care hospitals, outpatient rehabilitation clinics, and occupational health centers
• Key revenue drivers: Inpatient rehabilitation, critical illness recovery hospitals, outpatient therapy, and work injury/occupational health programs
• Home exchange/listing venue: New York Stock Exchange (SEM)
• Trading currency: USD

Select Medical Holdings: core business model

Operating primarily in the U.S., Select Medical Holdings runs networks of inpatient rehabilitation facilities, critical illness recovery hospitals, outpatient rehabilitation clinics, and occupational health centers, deriving most of its revenue from reimbursement-backed patient care and employer-focused occupational health services.

Valuation metrics and multiples for Select Medical Holdings

With the share price trading close to USD 16.50 and consensus expectations from seven Wall Street analysts compiled by MarketBeat indicating an average 12-month price target of USD 15.50 as of 05/27/2026, the implied valuation reflects both the cash offer level and prior stand-alone expectations (MarketBeat as of 05/27/2026).

According to the same MarketBeat overview as of 05/27/2026, analyst views on Select Medical Holdings currently cluster around a "hold" stance with a target range from USD 14.00 to USD 16.50 per share, underscoring that the agreed transaction price sits at the upper end of previously published targets and therefore embeds a valuation broadly consistent with the more optimistic broker assumptions about earnings and cash flow potential (MarketBeat as of 05/27/2026).

Conclusion

The currently traded level of Select Medical Holdings shares on the NYSE, hovering near the USD 16.50 agreed cash consideration, indicates that the U.S. market largely reflects the pending take-private offer and associated regulatory and shareholder steps. At the same time, the legal review reported by BFA Law as of 05/28/2026 introduces an additional layer of scrutiny around the fairness of the deal process for existing shareholders, which may influence perceptions of downside or upside risk around the offer level. For investors comparing stand-alone valuation benchmarks such as the MarketBeat consensus target of USD 15.50 as of 05/27/2026 with the proposed transaction price, the balance between agreed consideration, earnings profile, and deal certainty remains central to their ongoing assessment of the stock.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.